Universal CR Biomarker Panel for Rapid Compound Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack universal, tissue-specific biomarkers for caloric restriction (CR) that can be applied across different animal strains, making it difficult to identify compounds that mimic the beneficial effects of CR without global gene expression profiling.
Innovation Solution
Identification of a robust panel of universal CR biomarkers that are differentially expressed in specific tissues, allowing for the rapid screening of compounds that mimic CR effects across multiple animal strains, including murine, canine, feline, and human tissues, using gene panels and probes for detecting differential expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If global gene expression profiling is used to identify CR mimetics, then comprehensive coverage of gene expression changes is achieved, but the complexity and cost of screening increases significantly
Solution Approach 1:
The patent extracts a specific subset of genes (approximately 100 genes) from the entire genome that are most responsive to caloric restriction. This selected gene panel is then used for screening CR mimetics, replacing the need for comprehensive global gene expression profiling. The extraction principle reduces complexity while maintaining measurement precision by focusing only on the most informative genes.
Solution Approach 2:
The patent segments the genome into functional categories (metabolic pathways, stress response, cellular maintenance) and selects representative genes from each category. This segmentation approach allows the screening method to capture comprehensive gene expression changes across different biological processes without analyzing every gene, thus reducing overall screening complexity while maintaining comprehensive coverage.
2Measurement precision
If CR biomarkers are identified in a single mouse strain, then strain-specific accuracy is improved, but universality across different animal strains is lost
Solution Approach 1:
The patent develops a gene panel and screening method that functions universally across multiple animal strains (C57BL/6J, BALB/c, DBA/2, FVB/N) and species (mouse, rat, dog, cat, human). The selected genes show consistent differential expression patterns across these diverse genetic backgrounds, making the biomarkers and screening approach universally applicable rather than strain-specific.
Solution Approach 2:
The patent identifies genes whose expression changes (parameter) remain consistent across different animal strains despite genetic variations. By focusing on genes with stable expression patterns across strains, the method maintains measurement precision while achieving universality. The parameter being monitored (gene expression level) shows comparable changes across different genetic backgrounds.
3Productivity
If a small panel of CR biomarkers is used for screening, then screening speed and efficiency are improved, but the ability to accurately identify CR mimetics may be reduced
Solution Approach 1:
The patent selects genes that exhibit large magnitude changes in expression in response to caloric restriction. These genes show significant differential expression (large parameter changes) between CR and control conditions, which enhances the sensitivity and accuracy of CR mimetic identification. The selected biomarkers have expression changes that are both large in magnitude and consistent across strains, maintaining measurement precision while enabling rapid screening.
Solution Approach 2:
The patent applies different selection criteria to different genes in the panel, focusing on genes with specific characteristics (large expression changes, consistency across strains, involvement in key metabolic pathways). This local quality approach ensures that each gene in the panel contributes maximally to CR mimetic identification accuracy, maintaining high measurement precision with a relatively small number of biomarkers.
Data Source
AI summary
Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.